Quote | TransCode Therapeutics Inc. (NASDAQ:RNAZ)
Last: | $0.94 |
---|---|
Change Percent: | 0.46% |
Open: | $0.955 |
Close: | $0.94 |
High: | $0.99 |
Low: | $0.9359 |
Volume: | 104,637 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | TransCode Therapeutics Inc. (NASDAQ:RNAZ)
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
2024-06-10 07:12:38 ET More on TransCode Therapeutics Seeking Alpha’s Quant Rating on TransCode Therapeutics Historical earnings data for TransCode Therapeutics Read the full article on Seeking Alpha For further details see: TransCode Therapeutics ...
Message Board Posts | TransCode Therapeutics Inc. (NASDAQ:RNAZ)
Subject | By | Source | When |
---|---|---|---|
lil dip | The Night Stalker | investorshub | 05/20/2023 5:44:31 AM |
$RNAZ bears and bulls | subslover | investorshub | 05/18/2023 10:44:52 PM |
slow | The Night Stalker | investorshub | 05/18/2023 4:30:31 AM |
watching but $DRMA has my eye | The Night Stalker | investorshub | 05/15/2023 4:47:45 PM |
$RNAZ Good read | THEMASTERS_SON | investorshub | 05/14/2023 6:08:46 AM |
News, Short Squeeze, Breakout and More Instantly...
TransCode Therapeutics Inc. Company Name:
RNAZ Stock Symbol:
NASDAQ Market:
TransCode Therapeutics Inc. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from the NASDAQ Stock Market LLC (Nasdaq)...